PTPRT, protein tyrosine phosphatase receptor type T, 11122
N. diseases: 53; N. variants: 35
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
20 | 42588817 | intron variant | G/A | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
20 | 42091234 | intron variant | G/A | snv | 0.69 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
20 | 42441919 | intron variant | T/C | snv | 0.30 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
20 | 42352288 | splice region variant | G/A | snv |
|
0.700 | 0 | ||||||||||||||
|
20 | 42885815 | missense variant | A/G | snv | 4.0E-06 | 1.4E-05 |
|
0.700 | 0 | ||||||||||||
|
1.000 | 0.040 | 20 | 42894400 | intron variant | C/T | snv | 5.6E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42968931 | non coding transcript exon variant | G/A | snv | 6.0E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42928261 | intron variant | C/A | snv | 0.79 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42928665 | intron variant | A/C | snv | 9.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42931885 | intron variant | G/A | snv | 8.1E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42947823 | intron variant | C/T | snv | 9.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42912368 | intron variant | C/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 20 | 42923380 | intron variant | G/A | snv | 8.2E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42897322 | intron variant | G/A | snv | 3.6E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42899908 | intron variant | T/C | snv | 2.7E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42807024 | intron variant | T/C | snv | 0.14 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 20 | 42906248 | intron variant | C/A;T | snv | 6.4E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42903651 | intron variant | C/T | snv | 6.3E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42903960 | intron variant | G/C | snv | 9.5E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42888730 | intron variant | T/C | snv | 4.2E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42888751 | intron variant | C/T | snv | 4.2E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42888059 | intron variant | C/A;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 20 | 42970355 | intron variant | A/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42965385 | intron variant | A/G | snv | 9.2E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 20 | 42929484 | intron variant | T/C | snv | 1.6E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 |